2025 HCPCS Code G9421
Primary non-small cell lung cancer lung biopsy and cytology specimen report does not document classification into specific histologic type or histologic type does not follow iaslc guidance or is classified as nsclc-nos but without an explanation
TAGS: specific primary classification cytology specimen guidance explanation iaslc classified follow cancer biopsy document report histologic| Short Description | Lung cx bx rpt no doc class |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2015 |
| HCPCS Action Effective Date | January 01, 2022 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G9011 - Mccd, risk adj, level 5
- G9012 - Other specified case mgmt
- G9013 - Esrd demo bundle level i
- G9014 - Esrd demo bundle-level ii
- G9016 - Demo-smoking cessation coun
- G9017 - Amantadine hcl 100mg oral
- G9018 - Zanamivir,inhalation pwd 10m
- G9019 - Oseltamivir phosphate 75mg
- G9020 - Rimantadine hcl 100mg oral
- G9033 - Amantadine hcl oral brand
- G9034 - Zanamivir, inh pwdr, brand
- G9035 - Oseltamivir phosp, brand
- G9036 - Rimantadine hcl, brand
- G9037 - Intrpro req fr rec phys/qhcp
- G9038 - Co-management services
- G9050 - Oncology work-up evaluation
- G9051 - Oncology tx decision-mgmt
- G9052 - Onc surveillance for disease
- G9053 - Onc expectant management pt
- G9054 - Onc supervision palliative